These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK, Lyles KW, Haussler MR, Harrelson JM. J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [Abstract] [Full Text] [Related]
4. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism. Breslau NA, Moses AM, Pak CY. J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258 [Abstract] [Full Text] [Related]
6. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial. Wang O, Xing XP, Meng XW, Xia WB, Li M, Jiang Y, Hu YY, Liu HC. Chin Med J (Engl); 2009 Feb 05; 122(3):279-83. PubMed ID: 19236804 [Abstract] [Full Text] [Related]
9. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism. Unakami H, Furukawa Y, Sohn HE, Yumita S, Miura R, Hanew K, Yoshinaga K. Tohoku J Exp Med; 1982 Oct 05; 138(2):167-75. PubMed ID: 6294914 [Abstract] [Full Text] [Related]